Loading organizations...
§ Private Profile · Shanghai, Shanghai, China
Biotechnology company focused on cell therapy research and development.
Innovative Cellular Therapeutics has raised $75.2M across 2 funding rounds.
Innovative Cellular Therapeutics has raised $75.2M in total across 2 funding rounds.
Innovative Cellular Therapeutics has raised $75.2M across 2 funding rounds. Most recently, it raised $50.0M Series A in September 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 2, 2022 | $50M Series A | — | — | Announced |
| Apr 24, 2018 | $25.2M Venture Round | — | Gtja Investment Group, （刘缨） Helena LIU, Suyang Zhang | Announced |
Innovative Cellular Therapeutics has raised $75.2M in total across 2 funding rounds.
Innovative Cellular Therapeutics's investors include GTJA Investment Group, （刘缨） Helena Liu, Suyang Zhang.